Content about PwC

May 17, 2012

More than 80% of health plans would require a drug manufacturer to demonstrate a clear clinical benefit compared with current branded and generic treatments in order for its drug to be placed in the plan's formulary, according to a new survey.

NEW YORK — More than 80% of health plans would require a drug manufacturer to demonstrate a clear clinical benefit compared with current branded and generic treatments in order for its drug to be placed in the plan's formulary, according to a new survey.

June 20, 2011

The booming healthcare market, which is expected to reach 19.6% of gross domestic product by 2019, is driving a surge of activity from companies looking to develop new products and services to bolster profits and create more convenient patient care, according to a new report by PricewaterhouseCoopers’ Health Research Institute. 


NEW YORK — The booming healthcare market, which is expected to reach 19.6% of gross domestic product by 2019, is driving a surge of activity from companies looking to develop new products and services to bolster profits and create more convenient patient care, according to a new report by PricewaterhouseCoopers’ Health Research Institute.